A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma

NCT02035657 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Merkel Cell Carcinoma

Interventions

BIOLOGICAL: GLA-SE

Sponsor

Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)